Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
High Conviction Trades
Discover high conviction trades that caused a significant change in a fund's stake in a stock
Fund Manager Portfolios
Gain insights from the world’s largest funds and super investors
Analyst Insights
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Search
Sign in
Sign up
CVS Health
CVS
Market cap
$102B
Overview
Fund Trends
Analyst Outlook
Journalist POV
80.36
USD
+0.50
0.63%
At close
Updated
Nov 28, 4:00 PM EST
Pre-market
After hours
80.35
-0.01
0.01%
1D
5D
1M
3M
6M
YTD
1Y
5Y
10Y
1 day
0.63%
5 days
4.99%
1 month
-2.24%
3 months
11.39%
6 months
28.68%
Year to date
81.73%
1 year
34.27%
5 years
18.54%
10 years
-14.59%
Upgrade to unlock
Positive
Neutral
Negative
Sentiment
3-Months
Positive
Neutral
32.3%
Negative
Positive
Neutral
Negative
Positive
Zacks Investment Research
2 days ago
Why Is CVS Health (CVS) Up 4.1% Since Last Earnings Report?
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock?
Positive
Zacks Investment Research
2 days ago
CVS Health Delivers MBR Improvement: Is More Progress in the Cards?
CVS posts a sharper MBR as PDR impacts ease and government business strengthens while maintaining a cautious full-year outlook.
Positive
Invezz
3 days ago
These outperforming stocks are still cheap heading into 2026
US stocks have been in a sharp uptrend over the past seven months, with the benchmark S&P 500 index currently up more than 35% versus its year-to-date low in April. Still, a handful of outperformers are trading at relatively low forward valuations heading into 2026.
Positive
Zacks Investment Research
4 days ago
Battle of Benefits: Will UNH Deliver the Bigger Dose or CVS? (Revised)
CVS's rising margins, stronger guidance and sharper valuation edge make it stand out in the UNH vs. CVS upside debate.
Positive
Zacks Investment Research
4 days ago
Battle of Benefits: Will UNH Deliver the Bigger Dose or CVH?
CVS's rising margins, stronger guidance and sharper valuation edge make it stand out in the UNH vs. CVS upside debate.
Positive
Zacks Investment Research
5 days ago
CVS vs. WMT: Which Retail Pharmacy Powerhouse Looks Stronger Now?
CVS gains momentum with record revenues, stronger guidance and a cheaper valuation, standing out in the retail pharmacy comparison with WMT.
Negative
CNBC
5 days ago
Abortion pill makers brace for restrictions a year after Trump's election
Federal rules on the abortion pill mifepristone remain unchanged a year after President Donald Trump's election, but an FDA safety review has stirred new uncertainty. State enforcement and lawsuits are reshaping access and liability across a $6.9 billion abortion drugs market in the U.S., which is reliant on telehealth and mail delivery.
Neutral
GlobeNewsWire
6 days ago
Curaechoice Selects CVS Caremark at its PBM
All Active Curaechoice Members and their Families Will Have Access to CVS Pharmacies Nationwide Starting January 1 All Active Curaechoice Members and their Families Will Have Access to CVS Pharmacies Nationwide Starting January 1
Positive
Seeking Alpha
6 days ago
Wall Street Breakfast Podcast: Ubisoft Cracks Next Level With Tencent
Ubisoft Entertainment (OTCPK:UBSFY) surged nearly 9% after Tencent invested €1.16B in its Vantage Studios, boosting transformation and reducing debt. Tencent (OTCPK:TCEHY) now holds a 26.32% economic interest in Vantage Studios, while Ubisoft retains exclusive control and consolidation.
Neutral
PRNewsWire
10 days ago
CVS Health Names David Joyner Chair of the Board of Directors
WOONSOCKET, R.I. , Nov. 20, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that its Board of Directors has elected President and Chief Executive Officer David Joyner as Chair of the Board, effective January 1, 2026.
Show more
See News Rankings
Sign up
Sign in
Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
High Conviction Trades
Discover high conviction trades that caused a significant change in a fund's stake in a stock
Fund Manager Portfolios
Gain insights from the world’s largest funds and super investors
Analyst Insights
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Theme
Close